Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer

This study aimed to investigate the value of dynamic changes of midkine (MK) to monitor post-surgical patients with papillary thyroid cancer (PTC) who were managed with (131)I therapies. MK concentration at initial (131)I ablation therapy (MK1) as well as 10 to 12 months thereafter (MK2) was evaluat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Li, Ning, Zhang, Chunmei, Meng, Zhaowei, Xu, Ke, He, Xianghui, Yu, Yang, Jia, Qiang, Li, Xue, Liu, Xiangxiang, Wang, Xiaoran
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133610/
https://ncbi.nlm.nih.gov/pubmed/30200153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012242
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak